Pancreatic Cancer

Rákkutatás · Pancreatic cancer · TP53 · KRAS

This study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti‑cancer agents in participants with advanced cancer that has recurred/progressed.

Bizonyítékszint: Állatkísérletes. Állatmodellben vizsgálták.

Eredeti forrás

Kapcsolódó jelek

• Pancreatic cancer
• Modified FOLFIRINOX improves survival compared to gemcitabine in resected pancreatic cancer
• Recent Advances in the Treatment of Pancreatic Cancer
• Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
• EUROPAC Researching Hereditary Pancreatic Diseases